Psychopharmakologische Behandlungspraxis in Münchener Altenpflegeheimen

Molter-Bock, E.; Hasford, Joerg; Pfundstein, T.

doi:10.1007/s00391-006-0401-7

Cited by 24 publications

(13 citation statements)

References 49 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…More than 50% of residents had at least one prescription. These findings are in accordance with data reported by other German and international studies on nursing home residents (Alanen et al 2006, Molter-Bock et al 2006, French et al 2007. Physicians obviously ignore the overwhelming external evidence on lack of effectiveness of psychoactive agents in geriatric populations.…”

Section: Older Peoplesupporting

confidence: 90%

Restraint use among nursing home residents: cross‐sectional study and prospective cohort study

Meyer

Köpke²,

Haastert³

et al. 2009

Journal of Clinical Nursing

114

121

View full text Add to dashboard Cite

show abstract

Section: Older Peoplesupporting

confidence: 90%

Restraint use among nursing home residents: cross‐sectional study and prospective cohort study

Meyer

Köpke²,

Haastert³

et al. 2009

Journal of Clinical Nursing

114

121

View full text Add to dashboard Cite

show abstract

“…According to Meyer et al, 28.4% of 2367 residents in 30 German nursing homes received neuroleptics and 23.6% were prescribed anxiolytic or hypnotic medication, mostly butyrophenone [45]. These rates do not differ from the 56.4% antipsychotic drugs being prescribed to 888 residents in Munich nursing homes [46]. Similar results were obtained from Mann et al 2009 in Austria (antipsychotics 45.9%) [47], while the 31% reported in Italy was slightly lower [36].…”

Section: Discussionmentioning

confidence: 99%

Prescribing patterns in dementia: a multicentre observational study in a German network of CAM physicians

et al. 2011

View full text Add to dashboard Cite

BackgroundDementia is a major and increasing health problem worldwide. This study aims to investigate dementia treatment strategies among physicians specialised in complementary and alternative medicine (CAM) by analysing prescribing patterns and comparing them to current treatment guidelines in Germany.MethodsTwenty-two primary care physicians in Germany participated in this prospective, multicentre observational study. Prescriptions and diagnoses were reported for each consecutive patient. Data were included if patients had at least one diagnosis of dementia according to the 10th revision of the International Classification of Diseases during the study period. Multiple logistic regression was used to determine factors associated with a prescription of any anti-dementia drug including Ginkgo biloba.ResultsDuring the 5-year study period (2004-2008), 577 patients with dementia were included (median age: 81 years (IQR: 74-87); 69% female). Dementia was classified as unspecified dementia (57.2%), vascular dementia (25.1%), dementia in Alzheimer's disease (10.4%), and dementia in Parkinson's disease (7.3%). The prevalence of anti-dementia drugs was 25.6%. The phytopharmaceutical Ginkgo biloba was the most frequently prescribed anti-dementia drug overall (67.6% of all) followed by cholinesterase inhibitors (17.6%). The adjusted odds ratio (AOR) for receiving any anti-dementia drug was greater than 1 for neurologists (AOR = 2.34; CI: 1.59-3.47), the diagnosis of Alzheimer's disease (AOR = 3.28; CI: 1.96-5.50), neuroleptic therapy (AOR = 1.87; CI: 1.22-2.88), co-morbidities hypertension (AOR = 2.03; CI: 1.41-2.90), and heart failure (AOR = 4.85; CI: 3.42-6.88). The chance for a prescription of any anti-dementia drug decreased with the diagnosis of vascular dementia (AOR = 0.64; CI: 0.43-0.95) and diabetes mellitus (AOR = 0.55; CI: 0.36-0.86). The prescription of Ginkgo biloba was associated with sex (female: AOR = 0.41; CI: 0.19-0.89), patient age (AOR = 1.06; CI: 1.02-1.10), treatment by a neurologist (AOR = 0.09; CI: 0.03-0.23), and the diagnosis of Alzheimer's disease (AOR = 0.07; CI: 0.04-0.16).ConclusionsThis study provides a comprehensive analysis of everyday practice for treatment of dementia in primary care in physicians with a focus on CAM. The prescribing frequency for anti-dementia drugs is equivalent to those found in other German studies, while the administration of Ginkgo biloba is significantly higher.

show abstract

“…In einer Untersuchung in Münchener Altenheimen erhielten 56% der Bewohner Psychopharmaka, wobei 17% dieser Verordnungen vor mehr als 3 Monaten letztmalig überprüft wurde [7] Zahlreiche Psychopharmaka gelten als potenziell inadäquat für ältere Menschen, aufgrund ihrer stark sedierenden und anticholinergen Wirkungen, insbesondere für Heimbewohner [9]. Negative Einflüsse auf Kognition und Morbidität (u.a.…”

Section: Einführungunclassified

Arzneimitteltherapiesicherheit in Alten- und Pflegeheimen

Jaehde

Thürmann

2012

Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheit

View full text Add to dashboard Cite

Psychopharmakologische Behandlungspraxis in Münchener Altenpflegeheimen

Cited by 24 publications

References 49 publications

Restraint use among nursing home residents: cross‐sectional study and prospective cohort study

Restraint use among nursing home residents: cross‐sectional study and prospective cohort study

Prescribing patterns in dementia: a multicentre observational study in a German network of CAM physicians

Arzneimitteltherapiesicherheit in Alten- und Pflegeheimen

Contact Info

Product

Resources

About